Skip to main content
Equibles

Quantinno Capital Management LP

Position in ANIK — Anika Therapeutics, Inc.

CIK 1759654 NEW YORK, NY
Back to ANIK Full portfolio

Position in ANIK

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,271,409
+$446,932 QoQ
Shares Held
155,257
+23.4% QoQ
Ownership
1.16%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 134 holders
Holding Since
Jun 2025
5 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ANIK Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Quantinno Capital Management LP holds $225,769,469 across 37 Drug Manufacturers - Specialty & Generic names. ANIK ranks #15 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 1,974,908 $48,602,485
2 ZTS
Zoetis Inc.
 400,665 $28,791,786
3 TAK
Takeda Pharmaceutical Co Ltd
 1,402,650 $22,484,479
4 VTRS
Viatris Inc
 1,368,433 $21,730,716
5 UTHR
UNITED THERAPEUTICS Corp
 27,122 $14,695,513
6 PRGO
PERRIGO Co plc
 1,369,736 $14,231,557
7 NBIX
Neurocrine Biosciences Inc
 79,655 $13,425,053
8 HLN
Haleon plc
 1,151,189 $10,740,593

All Filings in ANIK

Export CSV
5 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,271,409 155,257
2026-03-31 $1,824,477 125,826
2025-12-31 $975,885 101,549
2025-09-30 $550,783 58,594
2025-06-30 $141,856 13,408